• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota

    2021-01-15 08:58:14YangLiZhongXinLiChenYangXieJingFanJiLvXinJianXuJianLvWenTaoKuaiYiTaoJia
    World Journal of Gastroenterology 2020年48期

    Yang Li, Zhong-Xin Li, Chen-Yang Xie, Jing Fan, Ji Lv, Xin-Jian Xu, .Jian Lv, Wen-Tao Kuai, Yi-Tao Jia

    Abstract

    Key Words: Colorectal cancer; Gegen Qinlian decoction; Immunity; Inflammation; Intestinal barrier function; Gut microbiota

    INTRODUCTION

    Colorectal cancer (CRC) is the third most common cancer worldwide[1]. Economic and social development and changes in lifestyle in China have resulted in a rapid increase in the incidence of CRC. At present, the main treatments for CRC are surgery, radiotherapy and chemotherapy, but the overall effect is not satisfactory. With the advent of immune checkpoint inhibitors, there is a new dawn in the treatment of malignant tumors such as melanoma[2]. However, the therapeutic effect of immune checkpoint inhibitors in CRC is not optimistic. The reason for this is that the tumor microenvironment is closely related to the effect of CRC treatment[3,4]. Based on the particular anatomy, the microenvironment of CRC is composed of intestinal microorganisms, their metabolites or secretions, and the intestinal barrier.

    It has been shown that the number of immune cells in patients with CRC is important for prognosis[5]. There must be sufficient immune cell infiltration in the tumor to ensure the killing effect. The proportion of T and natural killer (NK) cells in peripheral blood of CRC patients decreases, while the proportion of regulatory T (Treg) cells increases significantly, and the percentage of NKT cells is independently correlated with disease-free survival[6]. It has been found that cytokines such as interferon (IFN)-γ and interleukin (IL)-2 can improve the therapeutic effect of CRC by recruiting lymphocytes[7,8]. In addition, the increase in tumor necrosis factor (TNF)-α can promote the occurrence of chronic inflammation, but the inhibition of immune cells can be eliminated by blocking the signal transduction function of TNF-related receptors in T cells. In recent years, it has been found that serotonin (5-hydroxytryptamine, 5-HT) is not only known to regulate intestinal movement and secretion, but is also an important immunomodulator[9,10]. However, the relationship between 5-HT and poor prognosis, metastasis and recurrence of CRC is still controversial[11].

    The tight junction components are composed of occludin, zonula occludens (ZO)-1, ZO-2, ZO-3, claudin and junction adhesion molecules. The decreased expression of ZO-1 is related to cancer invasion[12]. The intestinal barrier function of patients with CRC is destroyed by decreased expression of ZO-1 and occludin[13]. The expression of ZO-1 and occludin is also decreased in inflammatory bowel diseases, while the level of nuclear factor (NF)-κB, TNF-α and IL-1 is significantly increased[14]. Evidence suggests that proinflammatory factor TNF-α can induce tumor invasion and metastasis by reducing the expression of E-cadherin and ZO-1[15].

    The uniqueness of CRC suggests that its occurrence and development, and destruction of the intestinal barrier may be inseparable from gut microbiota. There are approximately 1000 species of bacteria in the human intestinal system, more than 10 times the number of human eukaryotic cells[16]. If intestinal diseases do not take into account the role of bacteria, it is difficult to know the real cause of the disease. Recent studies have shown that changes in the type and number of gut microbiota play an important role in the occurrence and development of CRC[17]. It has been found that the combined action ofEscherichia coliandBacteroides fragiliscan promote the occurrence of CRC[18]. One study found that familial adenomatous polyposis eventually becomes cancerous due to the formation of bacterial biofilms that are mainly composed of the above two bacteria[19]. Other studies have also found thatBacteroides fragilis(B. fragilis) can activate the NF-κB pathway, leading to inflammation and ultimately carcinogenesis[20]. Yachidaet al[21]showed that the decreased abundance ofPrevotellaand increased abundance ofMegamonaswere significantly associated with progression of CRC. The Gustave Roussy Cancer Campus in France found that the increase in the relative abundance ofAkkermansia muciniphilacan promote the infiltration of immune cells into tumor tissues, which in turn improves the efficacy of immune checkpoint inhibitors[22-25]. The increase in harmful bacteria can inhibit the expression of mucin, thus weakening the protective effect of the intestinal barrier, which increases damage to the intestinal epithelium by intestinal toxic substances.

    Regulation of gut microbiota is expected to become an adjuvant therapy for CRC. Traditional Chinese medicine has unique advantages in this respect. According to traditional Chinese medicine, CRC originates from the damp-heat syndrome, which is roughly similar to the imbalance of gut microbiota in western medicine. Gegen Qinlian decoction (GQD) is a classical traditional Chinese medicine for the treatment of dampheat syndrome, which has a history of more than 2000 years. The formula contains four types of medicinal materials: Radix Puerariae, Radix Scutellariae, Rhizoma Coptidis and Radix Glycyrrhizae. GQD can be used in the treatment of type 2 diabetes and ulcerative colitis (UC)[26,27]. In our previous study, using the Traditional Chinese Medicine System Pharmacology Database, we found that GQD had a direct antitumor effect, and was combined with programmed cell death protein (PD)-1 inhibitors to treat microsatellite stable (MSS) tumor-bearing mice, which synergistically enhanced anti-PD-1 immunotherapy[28].

    However, the effect of GQD on intestinal mucosal barrier function and gut microbiota in patients with CRC has not been reported. In this study, based on previous animal studies, we determined the changes in immune cells, cytokines and intestinal barrier function in patients with CRC after GQD administration to assess the therapeutic mechanism of GQD in improving immune function, reducing inflammation and protecting intestinal barrier function.

    MATERIALS AND METHODS

    GQD preparation

    The herbal formula GQD is a combination of four medicinal herbs: Radix Puerariae (15 g), Scutellariae Radix (9 g), Coptidis Rhizoma (9 g), and liquorice (6 g) at a ratio of 5:3:3:2 (w/w/w/w). GQD was prepared at the pharmacy of the Fourth Hospital of Hebei Medical University, and was identified by two experienced pharmacists.

    Patient variables and medication standard

    Seventy patients with colon or rectal cancer diagnosed for the first time in the Fourth Hospital of Hebei Medical University were selected. Diagnosis and tumor-nodemetastasis (TNM) classification were made according to the Seventh Edition of TNM classification criteria issued by the Union for International Cancer Control (UICC). On admission, the patients were randomly divided into the control group (n= 37) and the treatment group (n= 33). The study was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University and followed the ethical standards stipulated in the Declaration of Helsinki. All patients gave informed consent. The control group received routine treatment and elective surgery after admission. The treatment group received routine treatment and oral GQD for 7 d (250 mL, twice daily) before surgery. The subjective and abdominal symptoms of the patients were observed and recorded.

    Flow cytometry

    Peripheral blood was collected at the beginning of the study in the control group, and was collected in the treatment group before and after medication. All peripheral blood was collected from veins with EDTA-Li micro-anticoagulant tubes. Blood was stained with anti-human CD45-FITC (REFA07749), anti-human CD3-PC5, anti-human CD4-RD1, anti-human CD8-ECD, anti-human CD(16+56)-PE (A07735), anti-human CD4-FITC (REFA07750), anti-human CD25-PE (REFA07774) and anti-human CD127-PC5 (REFA64617) (Beckman Coulter, CA, United States), which was divided into three tubes for testing. Measurement was carried out on a Fortessa Flow Cytometer (BD, San Jose, CA, United States). Analysis was performed with Flow Jo version 10 (Tree Star Inc., Ashland, OR, United States).

    Enzyme-linked immunosorbent assay

    Peripheral blood was collected at the beginning of the study in the control group, and was collected before and after medication in the treatment group. All sera were obtained by centrifugation and stored at -80°C. Commercially available enzyme-linked immunosorbent assay (ELISA) kits (ABclonal Biotechnology, Wuhan, China) were used to detect the levels of TNF-α, IFN-γ, IL-2, IL-6 and IL-10 in the serum of patients with CRC. 5-HT was detected using another ELISA kit (GeneTex, Hsinchu City, Taiwan).

    Immunohistochemistry

    Tumor and normal tissues in the control group and treatment group were removed after surgery. The colon and rectum specimens were harvested and embedded in paraffin blocks and cut into 4-μm-thick tissue sections. The morphological changes in normal tissues were confirmed by hematoxylin and eosin staining. For immunohistochemical staining, the paraffin-embedded slides were dewaxed using xylene and rehydrated using alcohol of graded concentrations. Endogenous peroxidase activity was eliminated by 3% H2O2for 15 min. The slides were then blocked with 5% goat serum for 20 min at 37°C, followed by primary antibody incubation overnight at 4°C. The next day, each sample was incubated with horseradish-peroxidase-labeled secondary antibody for 1 h at room temperature, followed by staining with the ready-to-use reagent DAB kit (ZSGB-BIO, Beijing, China). After dehydration and drying, the tissue sections were mounted with neutral gum and observed under a microscope (Olympus, Tokyo, Japan). Three high power visual fields were randomly selected for image acquisition, and image quantitative analysis was carried out with Image-Pro Plus 6.0 software. The average optical density of each protein was finally expressed by IOD value.

    Analysis of fecal 16S rDNA

    Feces were collected from the treatment group before and after medication for gut microbiota analyses by 16S rDNA. Microbial genomic DNA was extracted from fecal samples using a QIAamp DNA Stool Mini Kit (MoBio Laboratories Inc., Carlsbad, CA, United States). The 16S rDNA V4 region was amplified using the 515F primers (515FGTGCCAGCMGCCGCGGTAA) and 806R primers (GGACTACHVGGGTWTCTAAT). PCR product quantification, qualification and purification were performed. Library preparation and sequencing were performed on the MiSeq platform (Beijing Genomics Institute, Shenzhen, China). The 16S rDNA sequencing data were quality filtered using FLASH (Fast Length Adjustment of Short reads, version 1.2.11). Operational taxonomic units (OTUs) were picked at a 97% sequence similarity cut-off, and the identified taxonomy was then aligned using Silva (Release128 http://www.arbsilva.de). The RDP classifier (version 2.2) was used to classify OTUs at a given taxonomic rank.

    Statistical analysis

    Statistical analysis was performed using SPSS 21.0 software (Chicago, IL, United States). Measurement data are expressed as mean ± standard deviation. Comparisons between two groups were assessed using Student’s unpairedttests. The Student’s pairedttest was used to compare the results between pre-treatment and posttreatment. If it did not conform to the normality test, the rank sum test was used.P< 0.05 was selected as the point of minimal statistical significance in every comparison.

    RESULTS

    Comparison of clinical data between the control and treatment groups

    We compared clinical data between the control group and treatment group, including sex, age, tumor location, T stage, lymph node, and TNM stage (Table 1). The results showed that the clinical data of the two groups were consistent.

    Safety evaluation of GQD

    In the treatment group, nine patients had abdominal pain and distension, and 14 had diarrhea. Twelve patients complained of tenesmus. Following the administration of GQD, 12 of these 14 patients stated that their abdominal symptoms were better than those before treatment, including alleviation of diarrhea and reduced defecation, from five to three times per day. Another seven patients stated that the symptoms of tenesmus improved after taking GQD. No related adverse events were observed (Table 2).

    GQD enhanced immunity

    To determine the effect of GQD on immune function in patients with CRC, we measured immune cells in the control and treatment groups. There was no difference in the proportion of peripheral immune cells, including CD4+T cells, CD8+T cells, NK cells (CD3-CD16+CD56+), NKT cells (CD3+CD16+CD56+) and Treg cells (CD4+CD25+CD127dim) between the control and pre-treatment group (P> 0.05) (Figure 1). However, compared with the control group and pre-treatment group, the proportion of CD4+T cells was significantly increased in the post-treatment group (P< 0.05) (Figure 1A and B). There was no significant difference in CD8+T cells and NK cells among the three groups (P> 0.05) (Figure 1C-F). The proportion of NKT cells in the control group and pre-treatment group was 1.28% and 1.58%, respectively, and increased to 2.58% in the post-treatment group (P< 0.05) (Figure 1E and H). There was almost no difference in the proportion of Treg cells among the three groups (P> 0.05) (Figure 1G and I).

    GQD reduced inflammation

    To establish whether GQD reduced inflammation in patients with CRC, serum cytokine levels were measured with ELISA. The level of TNF-α in the post-treatment group was significantly lower than that in the control and pre-treatment groups. The average value of TNF-α in the control and pre-treatment groups was 12.85 pg/mL and 12.47 pg/mL, respectively, and the average value in the post-treatment group was 9.88 pg/mL (P< 0.05) (Figure 2A). The levels of other cytokines including IFN-γ, IL-2, IL-6 and IL-10 did not change significantly among the three groups (P> 0.05) (Figure 2B-E). In addition, compared with the pre-treatment group, GQD significantly reduced the level of 5-HT in the post-treatment group (P< 0.05). Although the level of 5-HT was also lower than that in the control group, it did not reach statistical significance (Figure 2F).

    GQD enhanced intestinal barrier function

    In the normal tissues of patients with CRC, the inflammatory reaction in the control group was more severe than that in the treatment group, in terms of the distribution of lymph nodes and destruction of intestinal mucosa (Figure 3A and B). To detect the effect of GQD on intestinal barrier function in patients with CRC, the expression of ZO-1, occludin, NF-κB and TNF-α in tumor and normal tissues was detected byimmunohistochemistry (Figure 4A). The expression of ZO-1 in tumor and normal tissues in the treatment group was significantly higher than that in the control group (P< 0.05) (Figure 4B). The expression of occludin in tumor tissues in the treatment group was significantly higher than that in the control group (P< 0.05), but there was no change in normal tissues between the control and treatment groups (P> 0.05) (Figure 4C). Similarly, compared with the control group, expression of NF-κB and TNF-α in tumor tissues of the treatment group was significantly reduced (P< 0.05) (Figure 4D and E). There was also no significant change in normal tissues between the control group and treatment group (P> 0.05) (Figure 4D and E). GQD prevented destruction of the intestinal barrier in patients with CRC.

    Table 1 Clinical data of patients with colorectal cancer in the two groups

    Table 2 Safety evaluation in patients with colorectal cancer in the treatment group

    GQD regulated the gut microbiota

    To determine the influence of GQD on the gut microbiota, 16S rDNA was used to detect the changes before and after treatment. Under 97% similarity, the number of OTUs in each sample was obtained. A Venn diagram showed 143 different species between the pre-treatment and post-treatment groups (Figure 5A). Partial least squares discriminant analysis demonstrated a notable clustering effect in the gut microbiota pre-treatment and post-treatment (Figure 5B). By visualizing the landscape of the gut microbiota in all feces samples, we found that the alpha and beta diversity of the gut microbiota was significantly lower in the post-treatment group than in the pretreatment group based on Ace, Chao and Shannon indices (Figure 5C and D).

    Figure 1 Gegen Qinlian decoction enhanced the immunity. A, C, E and G: Flow cytometry analysis of the proportions of CD4+T, CD8+T, natural killer (NK), NKT and Treg cells in the control group, the pre-treatment group and the post-treatment group of patients with colorectal cancer; B, D, F, H and I: Changes in the proportions of CD4+T, CD8+T, NK, NKT and Treg cells (aP < 0.05).

    We analyzed the gut microbiota for differences between the pre-treatment and posttreatment groups. Four dominant phyla were identified. Compared with pretreatment, the abundance of Bacteroidetes was increased, while the abundance of Firmicutes, Proteobacteria and Verrucomicrobia was decreased post-treatment (Figure 5E). When we compared the phylogenetic composition of common bacterial taxa at the genus level, we found thatBacteroides,AkkermansiaandPrevotellawere enriched and the abundance ofMegamonasandVeillonellawas decreased in the posttreatment group (Figure 5F and G).

    Figure 2 Gegen Qinlian decoction reduced inflammation. A-E: Changes in the concentration of cytokines [including tumor necrosis factor-α, interferon-γ, interleukin (IL)-2, IL-6, and IL-10] in serum among the control group, pre-treatment group and post-treatment group of patients with colorectal cancer (aP < 0.05); F: Changes in neurotransmitter 5-HT levels in serum among the three groups (aP < 0.05). TNF-α: Tumor necrosis factor-α; IFN-γ: Interferon-γ; IL: Interleukin; 5-HT: 5-Hydroxytryptamine.

    Figure 3 The morphological features of normal tissues in the control and treatment groups by HE staining (× 100 magnification). A: The control group; B: The treatment group.

    To analyze these findings further, the differential genes of gut microbiota between the two groups were enriched by KEGG function. We found functional differences in the gut microbiota between the pre-treatment and post-treatment groups, which included energy metabolism, immune system, nervous system and cancer (P< 0.05) (Figure 6). We suggest that GQD changed the functional state of patients with CRCviathe gut microbiota.

    Figure 4 Gegen Qinlian decoction enhanced intestinal barrier function. A: The expression of zonula occludens (ZO)-1, occludin, nuclear factor (NF)-κB and tumor necrosis factor (TNF)-α in tumor and normal tissues between the control and treatment groups determined by immunohistochemistry (× 400 magnification); B-E: Histogram showing the expression of ZO-1, occludin, NF-κB and TNF-α (aP < 0.05). ZO-1: Zonula occludens-1; NF-κB: Nuclear factor-κB; TNF-α: Tumor necrosis factor-α.

    DISCUSSION

    GQD is composed of Radix Puerariae, Radix Scutellariae, Rhizoma Coptidis and Radix Glycyrrhizae, the heat-clearing and detoxifying effects of which are well known. Wanget al[29]reported that GQD combined with other traditional Chinese medicine can prolong progression-free survival of patients with cholangiocarcinoma, and they also found that GQD restricts tumor growth in patients with CRC, but did not clarify the mechanism. In our study, we analyzed the immune status of peripheral blood and found that GQD increased the number of CD4+T cells and NKT cells; both of which contribute to the immune response against tumor cells. NKT cells are a group of special T cells with both T cell and NK cell receptors. Although the number is small, it can produce a large number of cytokines, but also reflects the state of immune metabolites, and can fight tumor cells together with CD4+T cells. Mossanenet al[30]found that CD4+T cells and NKT cells can work together against tumor cells. It has been shown that the decrease in the proportion of NK and NKT cells and the increase in the proportion of Treg cells in patients with CRC lead to poor efficacy of comprehensive treatment[31]. GQD regulates immune balance by inhibiting the differentiation of Treg cells in mice with influenza[32]. In this study, GQD had no significant effect on NK and Treg cells in peripheral blood, which may be related to the small sample size and activation state. Even though the proportion of NK and Treg cells in lymphocytes does not change significantly, their activation state may be changed. Future studies will increase the sample size and measure the activation state of immune cells to explore the effect of GQD on immune function.

    Chronic inflammation is one of the main risk factors for CRC. Patients with inflammatory bowel diseases, including UC and Crohn’s disease, have a higher risk of CRC than the general population[33,34]. Recently, it was reported that GQD has antiinflammatory and anti-infective effects. A variety of active components of GQD, such as baicalin, licorice flavonoids and berberine, can significantly reduce inflammation and oxidative stress. GQD also decreases diarrhea in piglets by reducing the levels of TNF-α and IL-6[35]. Wuet al[36]found that GQD extract could resist the increase in cytokines IL-1β, cyclo-oxygenase-2, intercellular adhesion molecule-1 and TNF-α induced by irinotecan, indicating that GQD has anti-inflammatory effects. In addition, TNF-α is an important inflammatory factor, which can significantly promote tumor progression. We found that GQD decreased the level of TNF-α, which verified that GQD could also reduce the inflammatory response in patients with CRC.

    Studies have shown that 5-HT is obviously associated with diarrhea[37]. GQD was originally used to treat diarrhea. The main components of GQD, such as puerarin and berberine, reduce secretion of 5-HT[38,39]. In addition, berberine improves visceral hypersensitivity in rats with diarrhea and irritable bowel syndrome by reducing the levels of 5-HT, substance P and calcitonin gene peptide. We found that the level of 5-HT in patients with CRC after taking GQD was significantly lower than before treatment. We speculate that the reduction of diarrhea in most patients with CRC may be closely related to a decrease in 5-HT by GQD.

    Figure 5 Gegen Qinlian decoction regulated the gut microbiota. A: Venn diagram of the total number of species shared between the pre-treatment and post-treatment groups; B: Principal coordinate analysis at the operational taxonomic unit level; C and D: Alpha diversity and beta diversity of the gut microbiota in the pre-treatment and post-treatment groups; E and F: Cumulative column chart of relative species abundance at the phylum and genus levels in the gut microbiome between the pre-treatment and post-treatment groups; G: Heatmap showing the changes in gut microbiota at the genus level between the pre-treatment and posttreatment groups. Columns represent samples and rows represent species. OUT: Operational taxonomic unit; PLS-DA: Principal coordinate analysis.

    The intestinal barrier can prevent harmful substances from entering the blood, thus avoiding a series of pathophysiological changes. It was found that the intestinal barrier function in patients with CRC was damaged, which was manifested by the decrease in intestinal tight junction proteins (ZO-1 and occludin)[40,41]. In addition, expression of ZO-1 and occludin in cancer tissues was significantly lower than that in paracancerous tissues in a colon cancer model induced by dextran sulfate sodium, suggesting that the intestinal barrier function of cancer tissue was destroyed, which eventually led to tumor progression, while the occurrence and development of colon tumor was significantly inhibited after restoration of intestinal barrier function[40]. Baicalin and puerarin, the main components of GQD, can reverse the epithelial–mesenchymal transition process of hepatocytes by upregulating the expression of ZO-1, occludin and claudin[42]. In our study, the expression of ZO-1 and occludin in CRC tissues after GQD administration was significantly higher than that in the control group. GQD also significantly promoted the expression of ZO-1 in normal tissues, while the expression of occludin in normal tissues was higher in both the control and treatment groups. These results suggest that GQD promotes the recovery of intestinal barrier function, which may be one of the reasons for the relief of diarrhea and other clinical symptoms.

    Figure 6 KEGG functional enrichment of differential genes in the gut microbiota of patients with colorectal cancer between the pretreatment and post-treatment groups.

    Inflammatory factors not only cause destruction of the intestinal barrier, but are also related to tumorigenesis. The decrease in TNF-α regulates intestinal epithelial permeability by upregulating the expression of ZO-1 and occludin proteins. It can increase the expression of adhesion molecules in endothelial cells and neutrophils, thus reducing the inflammation caused by migration, finally delaying tumor occurrence. In our study, consistent with the results of inflammatory factors in the peripheral blood, the expression of TNF-α and NF-κB in CRC tissues in the treatment group, which is significantly related to inflammation, was significantly lower than that in the control group. Although expression of TNF-α and NF-κB in the normal tissues of the treatment group was not significantly different from that of the control group, there was a decreasing trend. Therefore, we believe that GQD may upregulate intestinal tight junction proteins in the tumor microenvironment, improve intestinal inflammation, and protect the integrity of the intestinal barrier function, thus relieving clinical symptoms such as diarrhea in patients with CRC.

    Intestinal microecological disorders are closely related to the occurrence and development of CRC[43]. Because of its special location, the gut microbiota is an important part of the microenvironment of CRC. The abundance of harmful bacteria such asEscherichia coli,Bacteroides fragilisandFusobacterium nucleatumincreased, while the abundance of beneficial bacteria such asAkkermansiaandPrevotelladecreased. 16S rDNA sequencing was used to analyze the gut microbiota of feces from patients with CRC before and after GQD administration. Compared with pre-treatment, the abundance of Bacteroidetes was increased, while the abundance of Firmicutes, Proteobacteria and Verrucomicrobia was decreased post-treatment. The increase in Firmicutes and the decrease in Bacteroidetes have been proved to contribute to the development of cancer. At the genus level, the abundance ofBacteroides,AkkermansiaandPrevotellawas enriched and the abundance ofMegamonasandVeillonellawas decreased in the post-treatment group. It was reported that the abundance ofRuminococcusandPrevotellain the intestine of rats with CRC was significantly lower than that of healthy rats, which indirectly indicates that the abundance of these two bacteria is negatively related to the occurrence and development of CRC[44].Megamonascan promote the invasion and metastasis of CRC[18]. We demonstrated that GQD reduces harmful bacteria and increases beneficial bacteria, which is consistent with our previous animal experiments and literature reports, confirming that GQD may delay the development of CRC by regulating gut microbiota.

    Many scientists have found that the role of gut microbiota is not only limited to the intestinal tract, but also has an important impact on the normal function of the immune system[45]. A clinical study found that the abundance ofFusobacterium nucleatumin the intestine of CRC patients was inversely proportional to the density of CD3+T cells. This suggests that gut microbiota may be involved in immune regulation. It was reported thatAkkermansiaplays a vital role in intestinal homeostasis, and its abundance is also proportional to the effect of PD-1 inhibitors on CRC[23]. In addition, the abundance ofMegamonasis closely related to immune function and the inflammatory response. NKT cells play an important role in intestinal immunity, which can regulate immune cells, including NK cells, dendritic cells, CD4+T cells and CD8+T cells[46]. However, animal experiments have shown thatB. fragilisinhibits NKT cell activation through sphingolipids.

    The increase in short chain fatty acids (SCFAs), metabolites of gut microbiota, helps to reduce inflammation. Furthermore,Akkermansia,Butyricicoccus,ClostridiumandRuminococcusof the gut microbiota reduce the intestinal-related chronic inflammation by reducing IL-6, IL-22, IL-1β and TNF-α, and play an immunomodulatory role to inhibit tumorigenesis[47]. Liuet al[48]found that GQD can regulate the gut microbiota of animals with diarrhea and increase the relative abundance ofAkkermansia,BacteroidesandRuminococcus[35]. Researchers have shown that certain gut microbiota in human feces can increase the content of CD8+T cells, and metabolites of gut microbiota such as SCFA can reduce 5-HT[49,50]. Combined with these changes, we consider that GQD may reduce the level of 5-HT by regulating the gut microbiota, thereby improving diarrhea symptoms in patients with CRC.

    Our previous animal experiments showed that GQD increased the content of CD8+T cells and reduced the inflammatory response by increasing the Bacteroidales S24-7 group[28]. In this study, Bacteroidetes,PrevotellaandRuminococcusin the gut microbiota were significantly increased by GQD, while the abundance ofMegamonaswas significantly decreased. It is precisely these changes in the abundance of gut microbiota that enhance the immune function and reduce the inflammatory response of patients with CRC. Low-grade chronic inflammation and damage to the intestinal barrier function are not only related to the changes in intestinal microorganisms, but also to the occurrence and development of CRC. In this study, the abundance ofAkkermansiaof patients with CRC after GQD administration was increased. AlthoughAkkermansiause mucin as the source of energy, a large number of observations have confirmed thatAkkermansiahas a positive regulatory effect on the thickness of the gut mucous layer and integrity of the intestinal barrier[51].

    Puerarin, the main component of GQD, can increase the abundance ofAkkermansiato promote the expression of ZO-1 and occludin, thereby protecting the intestinal barrier function[52]. Activation of the LPS–TLR4–NF-κB pathway has been shown to be involved in inflammatory processes and malignant transformation[53]. SCFAs are present in metabolites ofBacteroidesandPrevotella. SCFAs (especially butyrate) protect the intestinal barrier function by increasing the expression of claudin-1, ZO-1 and mucin[54,55]. SCFAs can also reduce the expression of NF-κB and IL-18 to inhibit inflammation and regulate the intestinal microecology[56]. These studies show that the gut microbiota and its metabolites play a pivotal role in protecting the integrity of the intestinal tract. Although we did not detect the metabolites of gut microbiota, GQD increased the abundance ofBacteroides,PrevotellaandAkkermansia, which increase the expression of ZO-1 and occludin, inhibit the NF-κB inflammatory signaling pathway, and reduce the inflammatory factor TNF-α in blood and tumor tissues, thereby protecting the intestinal barrier function and inhibiting the development of intestinal inflammation.

    KEGG function is significantly enriched in the immune system, energy metabolism, nervous system, and cancer, which indicates that the gut microbiota remodeled by GQD is related to the above functions. Our research shows that GQD can increase the number of immune cells, especially CD4+T cells and NKT cells, reduce the inflammatory response, and protect the intestinal barrier function. The abovementioned effects of GQD are likely to be achieved by regulating the gut microbiota, and it has good clinical application prospects.

    CONCLUSION

    GQD improves intestinal barrier function by reducing the systemic inflammatory reaction and enhancing immune function in patients with CRC. These functions may be achieved through regulation of the gut microbiota.

    ARTICLE HIGHLIGHTS

    Research conclusions

    GQD enhances the immunity and protects intestinal barrier function in patients with CRC by regulating the composition of gut microbiota.

    Research perspectives

    GQD has good clinical application prospects.

    成人特级av手机在线观看| 久久亚洲精品不卡| 国产乱人伦免费视频| av天堂中文字幕网| 中文亚洲av片在线观看爽| 日本黄色视频三级网站网址| 日韩精品中文字幕看吧| 国产乱人伦免费视频| 亚洲中文字幕日韩| 日本黄大片高清| 久久久久久九九精品二区国产| 12—13女人毛片做爰片一| 神马国产精品三级电影在线观看| 成人三级黄色视频| 国产91精品成人一区二区三区| 久久久水蜜桃国产精品网| 欧美xxxx黑人xx丫x性爽| 色av中文字幕| 三级男女做爰猛烈吃奶摸视频| 亚洲国产看品久久| 91在线精品国自产拍蜜月 | 怎么达到女性高潮| 国产高清视频在线播放一区| 丰满人妻一区二区三区视频av | 禁无遮挡网站| 免费在线观看日本一区| 国产三级中文精品| 叶爱在线成人免费视频播放| 免费在线观看亚洲国产| 中文资源天堂在线| 国产精品久久久av美女十八| 中亚洲国语对白在线视频| 亚洲欧美精品综合久久99| 亚洲专区字幕在线| 精品久久久久久,| 听说在线观看完整版免费高清| 可以在线观看的亚洲视频| 男女那种视频在线观看| 成人特级黄色片久久久久久久| 午夜免费观看网址| 1024手机看黄色片| 黑人操中国人逼视频| 男人舔女人的私密视频| 国产精品女同一区二区软件 | 一区福利在线观看| 国产成人影院久久av| 美女扒开内裤让男人捅视频| 国产欧美日韩精品一区二区| 999久久久国产精品视频| 少妇人妻一区二区三区视频| 精品久久久久久久毛片微露脸| bbb黄色大片| 99精品在免费线老司机午夜| 女人高潮潮喷娇喘18禁视频| 国内毛片毛片毛片毛片毛片| 一卡2卡三卡四卡精品乱码亚洲| 免费看光身美女| 亚洲成人中文字幕在线播放| 亚洲七黄色美女视频| 中出人妻视频一区二区| 三级男女做爰猛烈吃奶摸视频| 国产蜜桃级精品一区二区三区| 嫩草影院入口| 99热精品在线国产| 亚洲成人精品中文字幕电影| 天天躁日日操中文字幕| 淫妇啪啪啪对白视频| 国产99白浆流出| 岛国视频午夜一区免费看| 国产亚洲av嫩草精品影院| 国产 一区 欧美 日韩| 国产亚洲av高清不卡| 亚洲激情在线av| 又大又爽又粗| 精品久久久久久久久久免费视频| 老熟妇仑乱视频hdxx| 床上黄色一级片| a级毛片在线看网站| 91av网站免费观看| 国产精品日韩av在线免费观看| avwww免费| 18禁国产床啪视频网站| 90打野战视频偷拍视频| 亚洲国产欧美一区二区综合| 亚洲国产色片| 国产成人欧美在线观看| 99热这里只有精品一区 | 一本综合久久免费| 成人特级黄色片久久久久久久| 国产三级在线视频| 国产伦精品一区二区三区视频9 | 99re在线观看精品视频| 19禁男女啪啪无遮挡网站| 亚洲精华国产精华精| 美女高潮的动态| 一级毛片女人18水好多| 国产黄片美女视频| 国产极品精品免费视频能看的| 精品久久久久久久久久久久久| 婷婷丁香在线五月| 免费观看精品视频网站| 国产亚洲精品av在线| 日韩精品中文字幕看吧| 99久久久亚洲精品蜜臀av| 精品久久久久久,| 亚洲熟妇中文字幕五十中出| 一个人免费在线观看电影 | 波多野结衣巨乳人妻| 亚洲精品一卡2卡三卡4卡5卡| 又粗又爽又猛毛片免费看| 国产伦精品一区二区三区视频9 | 久久婷婷人人爽人人干人人爱| 视频区欧美日本亚洲| 免费看十八禁软件| 欧美国产日韩亚洲一区| 国产1区2区3区精品| 精品一区二区三区视频在线观看免费| 午夜免费观看网址| 99国产精品一区二区蜜桃av| 亚洲性夜色夜夜综合| 嫩草影院入口| 亚洲人成伊人成综合网2020| 日本一本二区三区精品| 免费av不卡在线播放| 97人妻精品一区二区三区麻豆| 亚洲精品美女久久av网站| 性色av乱码一区二区三区2| 一边摸一边抽搐一进一小说| 精品熟女少妇八av免费久了| 国产69精品久久久久777片 | 国产精品久久久久久精品电影| 视频区欧美日本亚洲| 色播亚洲综合网| 久久这里只有精品19| 国产高清videossex| 国产精品亚洲美女久久久| 12—13女人毛片做爰片一| 国产精品免费一区二区三区在线| 久久久国产成人免费| 看黄色毛片网站| 99国产极品粉嫩在线观看| 亚洲精品中文字幕一二三四区| 日韩欧美在线二视频| 成人特级黄色片久久久久久久| 国产一区二区激情短视频| 色视频www国产| 久久久久国产精品人妻aⅴ院| 国产精品久久久久久精品电影| 欧美色视频一区免费| 国产亚洲精品综合一区在线观看| 啦啦啦免费观看视频1| 99久久无色码亚洲精品果冻| 窝窝影院91人妻| 亚洲成人精品中文字幕电影| 欧美色视频一区免费| 中文资源天堂在线| 精品乱码久久久久久99久播| 欧美黄色淫秽网站| 精品国产亚洲在线| 在线观看美女被高潮喷水网站 | 又大又爽又粗| 国产伦一二天堂av在线观看| 波多野结衣高清作品| 在线看三级毛片| 日韩国内少妇激情av| 久久久成人免费电影| 好男人在线观看高清免费视频| 亚洲国产日韩欧美精品在线观看 | 国产精品久久视频播放| 91九色精品人成在线观看| 少妇丰满av| 香蕉国产在线看| 中文资源天堂在线| 色吧在线观看| 桃色一区二区三区在线观看| 亚洲中文字幕一区二区三区有码在线看 | 别揉我奶头~嗯~啊~动态视频| 国产伦在线观看视频一区| 久久99热这里只有精品18| 一进一出抽搐动态| 又紧又爽又黄一区二区| 最近视频中文字幕2019在线8| 欧美极品一区二区三区四区| 好男人电影高清在线观看| 日日干狠狠操夜夜爽| 国产高清三级在线| 亚洲成人精品中文字幕电影| 精品熟女少妇八av免费久了| 国产精品亚洲一级av第二区| 午夜亚洲福利在线播放| 日韩大尺度精品在线看网址| 久久精品夜夜夜夜夜久久蜜豆| 欧美色视频一区免费| 日本熟妇午夜| 午夜福利免费观看在线| 国产高清三级在线| 国内揄拍国产精品人妻在线| 国产精品 国内视频| 午夜福利成人在线免费观看| 亚洲av片天天在线观看| 女生性感内裤真人,穿戴方法视频| 亚洲av成人av| 久久九九热精品免费| 亚洲在线自拍视频| av在线蜜桃| 亚洲av成人av| 禁无遮挡网站| 亚洲在线观看片| 我的老师免费观看完整版| 亚洲18禁久久av| 美女cb高潮喷水在线观看 | 久久精品国产亚洲av香蕉五月| 狠狠狠狠99中文字幕| 午夜福利成人在线免费观看| 99国产精品一区二区三区| 午夜福利18| 午夜亚洲福利在线播放| 老司机福利观看| 国语自产精品视频在线第100页| 久久亚洲精品不卡| 岛国在线免费视频观看| 中文字幕av在线有码专区| av欧美777| 操出白浆在线播放| 久久精品91蜜桃| 国产黄色小视频在线观看| 亚洲欧美日韩高清在线视频| 国产精品av视频在线免费观看| 在线观看日韩欧美| 亚洲 欧美 日韩 在线 免费| 日本免费a在线| 精品久久久久久久久久免费视频| 男女做爰动态图高潮gif福利片| 日韩有码中文字幕| 久久精品91蜜桃| 一夜夜www| 怎么达到女性高潮| 国产私拍福利视频在线观看| 99热这里只有精品一区 | 香蕉国产在线看| 成人高潮视频无遮挡免费网站| 国产欧美日韩精品亚洲av| 欧美日韩亚洲国产一区二区在线观看| 久久人人精品亚洲av| 亚洲五月婷婷丁香| 又黄又爽又免费观看的视频| 国内毛片毛片毛片毛片毛片| 啦啦啦韩国在线观看视频| 少妇丰满av| 精品无人区乱码1区二区| 亚洲成人免费电影在线观看| 精品久久久久久久末码| 天天一区二区日本电影三级| 亚洲性夜色夜夜综合| 国产在线精品亚洲第一网站| 久久婷婷人人爽人人干人人爱| 国产视频内射| 欧美+亚洲+日韩+国产| 亚洲精华国产精华精| 好看av亚洲va欧美ⅴa在| 18禁国产床啪视频网站| 婷婷丁香在线五月| www.自偷自拍.com| 国产精品美女特级片免费视频播放器 | 亚洲av电影在线进入| 欧美大码av| 97人妻精品一区二区三区麻豆| 在线观看免费午夜福利视频| 九九在线视频观看精品| 精品久久久久久久末码| 免费无遮挡裸体视频| 国产精品爽爽va在线观看网站| 最近最新中文字幕大全电影3| 在线视频色国产色| 欧美丝袜亚洲另类 | 99热6这里只有精品| 全区人妻精品视频| 中国美女看黄片| 超碰成人久久| 国产伦人伦偷精品视频| 好看av亚洲va欧美ⅴa在| 床上黄色一级片| av黄色大香蕉| 日韩欧美一区二区三区在线观看| 狂野欧美白嫩少妇大欣赏| 亚洲自偷自拍图片 自拍| 国产精品久久久人人做人人爽| 视频区欧美日本亚洲| 精品熟女少妇八av免费久了| 波多野结衣巨乳人妻| 日韩精品青青久久久久久| 国产亚洲欧美在线一区二区| bbb黄色大片| 99久久99久久久精品蜜桃| 丁香欧美五月| 国模一区二区三区四区视频 | 婷婷精品国产亚洲av在线| 精品免费久久久久久久清纯| 法律面前人人平等表现在哪些方面| 成人特级黄色片久久久久久久| 国产亚洲欧美在线一区二区| 久久久久国产一级毛片高清牌| 三级男女做爰猛烈吃奶摸视频| 亚洲精品美女久久av网站| 欧美3d第一页| 国产亚洲av高清不卡| 精品久久久久久久毛片微露脸| 日本三级黄在线观看| 99久久久亚洲精品蜜臀av| 国产高清有码在线观看视频| 亚洲自偷自拍图片 自拍| 亚洲av电影在线进入| 成人一区二区视频在线观看| 国产av不卡久久| 黑人欧美特级aaaaaa片| 国产私拍福利视频在线观看| 国产 一区 欧美 日韩| 草草在线视频免费看| 精品午夜福利视频在线观看一区| 在线视频色国产色| 99久国产av精品| 男女午夜视频在线观看| 成人鲁丝片一二三区免费| 波多野结衣高清无吗| 久9热在线精品视频| 欧美三级亚洲精品| 欧美成狂野欧美在线观看| 亚洲专区国产一区二区| 欧美成人一区二区免费高清观看 | 久久久色成人| 一区二区三区激情视频| 成年人黄色毛片网站| 又紧又爽又黄一区二区| 俺也久久电影网| 黄色日韩在线| 18禁裸乳无遮挡免费网站照片| 亚洲专区国产一区二区| 十八禁人妻一区二区| 国产精品99久久99久久久不卡| 岛国在线免费视频观看| 手机成人av网站| 国产成人精品久久二区二区91| 特级一级黄色大片| 亚洲精品中文字幕一二三四区| 国产精品99久久久久久久久| 狠狠狠狠99中文字幕| 老司机深夜福利视频在线观看| or卡值多少钱| 国产伦一二天堂av在线观看| 亚洲欧美一区二区三区黑人| 手机成人av网站| 成在线人永久免费视频| 日韩欧美在线二视频| 天天一区二区日本电影三级| 国产激情欧美一区二区| 99re在线观看精品视频| 丝袜人妻中文字幕| 国产激情欧美一区二区| 18禁黄网站禁片免费观看直播| 久久九九热精品免费| 国产精品亚洲美女久久久| 99热只有精品国产| 最新在线观看一区二区三区| 一级黄色大片毛片| 视频区欧美日本亚洲| 亚洲第一电影网av| 18禁观看日本| 精品久久久久久久末码| 亚洲国产欧美网| 精品国产美女av久久久久小说| 久久久久性生活片| 精品不卡国产一区二区三区| 久久久精品欧美日韩精品| 中文在线观看免费www的网站| 午夜福利18| 99在线视频只有这里精品首页| 亚洲午夜精品一区,二区,三区| 成年女人永久免费观看视频| 成人亚洲精品av一区二区| 国产真人三级小视频在线观看| 色综合欧美亚洲国产小说| 亚洲国产看品久久| 99久久成人亚洲精品观看| 一进一出好大好爽视频| 亚洲人成网站高清观看| 99在线人妻在线中文字幕| 成人欧美大片| 精品久久久久久久毛片微露脸| 91九色精品人成在线观看| 香蕉丝袜av| 不卡av一区二区三区| 亚洲欧美一区二区三区黑人| 黄色成人免费大全| 亚洲成av人片免费观看| 日本免费一区二区三区高清不卡| 99久久精品国产亚洲精品| 色在线成人网| 法律面前人人平等表现在哪些方面| 九九久久精品国产亚洲av麻豆 | 不卡av一区二区三区| 国产成人精品无人区| 老熟妇乱子伦视频在线观看| 十八禁人妻一区二区| 999久久久精品免费观看国产| 99在线视频只有这里精品首页| 日韩免费av在线播放| 国产美女午夜福利| 日本与韩国留学比较| 国产v大片淫在线免费观看| 少妇丰满av| 国产av一区在线观看免费| 91麻豆精品激情在线观看国产| 观看免费一级毛片| 国产一区二区在线av高清观看| 99国产精品99久久久久| 91av网站免费观看| 亚洲精品一卡2卡三卡4卡5卡| 久久久久九九精品影院| 一进一出抽搐gif免费好疼| 午夜激情欧美在线| 美女大奶头视频| www.精华液| 欧美午夜高清在线| 99精品在免费线老司机午夜| 极品教师在线免费播放| 国产精品一区二区三区四区免费观看 | 一本久久中文字幕| 午夜福利高清视频| 精品一区二区三区四区五区乱码| 少妇人妻一区二区三区视频| 黄色丝袜av网址大全| 亚洲av免费在线观看| 精品国内亚洲2022精品成人| 黄色视频,在线免费观看| 在线十欧美十亚洲十日本专区| a级毛片在线看网站| 精品国产亚洲在线| x7x7x7水蜜桃| 国产一区二区在线观看日韩 | 丁香六月欧美| 成人性生交大片免费视频hd| 男女那种视频在线观看| 久久久国产精品麻豆| 特级一级黄色大片| 欧美成人一区二区免费高清观看 | 非洲黑人性xxxx精品又粗又长| 久久国产乱子伦精品免费另类| 特大巨黑吊av在线直播| 亚洲激情在线av| 99热精品在线国产| 欧美日韩乱码在线| 三级男女做爰猛烈吃奶摸视频| 香蕉国产在线看| 男人舔奶头视频| 久久久久国产一级毛片高清牌| 国产蜜桃级精品一区二区三区| 亚洲在线观看片| 亚洲无线在线观看| 久久久久国产精品人妻aⅴ院| 日韩高清综合在线| 18禁观看日本| 成人三级做爰电影| 97超视频在线观看视频| 午夜日韩欧美国产| 夜夜爽天天搞| 人妻夜夜爽99麻豆av| 精品无人区乱码1区二区| www日本黄色视频网| 99久久成人亚洲精品观看| 男女床上黄色一级片免费看| 中文资源天堂在线| 欧美xxxx黑人xx丫x性爽| 免费在线观看影片大全网站| 欧美黄色淫秽网站| 1024香蕉在线观看| 小蜜桃在线观看免费完整版高清| 99国产精品一区二区蜜桃av| 身体一侧抽搐| 国产单亲对白刺激| 日韩欧美三级三区| 亚洲成av人片在线播放无| 亚洲aⅴ乱码一区二区在线播放| 中文亚洲av片在线观看爽| 日韩有码中文字幕| 日韩 欧美 亚洲 中文字幕| xxx96com| 舔av片在线| 国产精品99久久99久久久不卡| 最近在线观看免费完整版| 国产野战对白在线观看| 黄色丝袜av网址大全| 国产一区二区激情短视频| 日韩国内少妇激情av| 俺也久久电影网| 国产三级中文精品| 校园春色视频在线观看| 国产av不卡久久| 搞女人的毛片| 男插女下体视频免费在线播放| 国产三级中文精品| svipshipincom国产片| 国产精品一区二区三区四区久久| 国产午夜精品论理片| 精品久久久久久久末码| 伊人久久大香线蕉亚洲五| 欧美极品一区二区三区四区| 亚洲精品美女久久av网站| 亚洲自偷自拍图片 自拍| 俺也久久电影网| 午夜福利在线在线| 级片在线观看| or卡值多少钱| 女同久久另类99精品国产91| 免费在线观看成人毛片| 国产精品av视频在线免费观看| 美女被艹到高潮喷水动态| av视频在线观看入口| 国内精品美女久久久久久| 欧美中文日本在线观看视频| 99精品欧美一区二区三区四区| 欧美乱码精品一区二区三区| 久久久久九九精品影院| 2021天堂中文幕一二区在线观| 成人18禁在线播放| 琪琪午夜伦伦电影理论片6080| 曰老女人黄片| 别揉我奶头~嗯~啊~动态视频| 国产一区在线观看成人免费| 亚洲在线观看片| 国产一区二区三区在线臀色熟女| 91在线观看av| 制服丝袜大香蕉在线| 欧美乱色亚洲激情| 18禁国产床啪视频网站| 亚洲人成伊人成综合网2020| 女人被狂操c到高潮| 老熟妇仑乱视频hdxx| bbb黄色大片| 精品福利观看| 久久久国产精品麻豆| 午夜日韩欧美国产| 欧美性猛交╳xxx乱大交人| 久久精品亚洲精品国产色婷小说| 男女之事视频高清在线观看| 国产免费男女视频| 欧美激情在线99| 黄色日韩在线| 高清毛片免费观看视频网站| 亚洲 欧美 日韩 在线 免费| 国产淫片久久久久久久久 | 夜夜爽天天搞| 亚洲成人免费电影在线观看| 真人一进一出gif抽搐免费| 一进一出抽搐gif免费好疼| 国产麻豆成人av免费视频| 日本与韩国留学比较| 99久久综合精品五月天人人| 久久亚洲精品不卡| 最新美女视频免费是黄的| 天堂√8在线中文| 欧美日本视频| 18禁裸乳无遮挡免费网站照片| 国产野战对白在线观看| 久久久精品大字幕| 亚洲aⅴ乱码一区二区在线播放| 精品电影一区二区在线| 日韩欧美在线二视频| 噜噜噜噜噜久久久久久91| 国产亚洲av高清不卡| 欧美丝袜亚洲另类 | 欧美高清成人免费视频www| 亚洲精品久久国产高清桃花| 婷婷精品国产亚洲av在线| 国产又黄又爽又无遮挡在线| 哪里可以看免费的av片| 久久精品国产综合久久久| 欧美激情在线99| 亚洲熟女毛片儿| 毛片女人毛片| 嫩草影视91久久| 亚洲精品456在线播放app | a级毛片在线看网站| 999久久久精品免费观看国产| 可以在线观看的亚洲视频| 天天躁狠狠躁夜夜躁狠狠躁| 法律面前人人平等表现在哪些方面| 18禁国产床啪视频网站| 中文字幕久久专区| 最近视频中文字幕2019在线8| 在线十欧美十亚洲十日本专区| 免费看十八禁软件| 亚洲成人久久性| aaaaa片日本免费| 五月伊人婷婷丁香| 一本精品99久久精品77| 99在线人妻在线中文字幕| 中文资源天堂在线| 色播亚洲综合网| 两个人的视频大全免费| 亚洲人与动物交配视频| 亚洲国产精品sss在线观看| 亚洲精品美女久久久久99蜜臀| 手机成人av网站| 99久久精品国产亚洲精品| 亚洲国产欧洲综合997久久,| 国产黄片美女视频| 国产亚洲欧美98| 亚洲精品美女久久av网站| 三级男女做爰猛烈吃奶摸视频| 性欧美人与动物交配| 国产三级黄色录像| 又紧又爽又黄一区二区| 亚洲第一欧美日韩一区二区三区| 色综合站精品国产| 熟女电影av网|